Role of BCR in the resistance of BCR/ABL harboring the T315I mutation

被引：0
|
作者：
Rafiei, A. [1 ]
Metodieva, A. T. [1 ]
Ottmann, O. G. [1 ]
Serve, H. [1 ]
Ruthardt, M. [1 ]
Mian, A. A. [1 ]
机构：
[1] Goethe Univ Frankfurt, Med Klin 2, Frankfurt, Germany
来源：
ONKOLOGIE | 2011年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5 / 5
页数：1
相关论文
共 50 条
  • [31] MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia
    Giles, F. J.
    Swords, R. T.
    Nagler, A.
    Hochhaus, A.
    Ottmann, O. G.
    Rizzieri, D. A.
    Talpaz, M.
    Clark, J.
    Watson, P.
    Xiao, A.
    Zhao, B.
    Bergstrom, D.
    Le Coutre, P. D.
    Freedman, S. J.
    Cortes, J. E.
    LEUKEMIA, 2013, 27 (01) : 113 - 117
  • [32] Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR
    Masahide Yamamoto
    Kazuhiko Kakihana
    Kazuteru Ohashi
    Toshikazu Yamaguchi
    Kenichi Tadokoro
    Hideki Akiyama
    Hisashi Sakamaki
    International Journal of Hematology, 2009, 89 : 482 - 488
  • [33] The ''Gatekeeper'' Mutation T315I in BCR/ABL Confers Additional Oncogenic Activities to Philadelphia Chromosome Positive Leukemia
    Zafar, Usva
    Yusuf, Mohammed
    Chakraborty, Rikhia
    Lalani, El-Nasir M. A.
    Mian, Afsar Ali
    BLOOD, 2019, 134
  • [34] Emerging strategies for the treatment of mutant Bcr-Abl T315I myeloid leukemia
    Mughal, Tariq I.
    Goldman, John M.
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 : S81 - S84
  • [35] Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR
    Yamamoto, Masahide
    Kakihana, Kazuhiko
    Ohashi, Kazuteru
    Yamaguchi, Toshikazu
    Tadokoro, Kenichi
    Akiyama, Hideki
    Sakamaki, Hisashi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (04) : 482 - 488
  • [36] The rise and fall of gatekeeper mutations? The BCR-ABL1 T315I paradigm
    Gibbons, Don L.
    Pricl, Sabrina
    Kantarjian, Hagop
    Cortes, Jorge
    Quintas-Cardama, Alfonso
    CANCER, 2012, 118 (02) : 293 - 299
  • [37] Overcoming Bcr-Abl T315I mutation by combination of GNF-2 and ATP competitors in an Abl-independent mechanism
    Mamduh Khateb
    Nili Ruimi
    Hazem Khamisie
    Yousef Najajreh
    Afsar Mian
    Anna Metodieva
    Martin Ruthardt
    Jamal Mahajna
    BMC Cancer, 12
  • [38] E T315I MUTATION CONFERS RESISTANCE AGAINST SMALL MOLECULES BY RESTORING THE ABL-KINASE ACTIVITY ACCOMPANIED BY TRANSPHOSPHORYLATION OF ENDOGENOUS BCR, EVEN IN LOSS-OF-FUNCTION MUTANTS OF BCR/ABL
    Ruthardt, M.
    Mian, M.
    Schuell, M.
    Zhao, Z.
    Oancea, C.
    Beissert, T.
    Serve, H.
    Ottmann, O. G.
    Ruthardt, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 130 - 130
  • [39] Cleavage of BCR-ABL transcripts at the T315I point mutation by DNAzyme promotes apoptotic cell death in imatinib-resistant BCR-ABL leukemic cells
    Kim, J. E.
    Yoon, S.
    Choi, B-R
    Kim, K. P.
    Cho, Y-H
    Jung, W.
    Kim, D-W
    Oh, S.
    Kim, D-E
    LEUKEMIA, 2013, 27 (08) : 1650 - 1658
  • [40] Overcoming Bcr-Abl T315I mutation by combination of GNF-2 and ATP competitors in an Abl-independent mechanism
    Khateb, Mamduh
    Ruimi, Nili
    Khamisie, Hazem
    Najajreh, Yousef
    Mian, Afsar
    Metodieva, Anna
    Ruthardt, Martin
    Mahajna, Jamal
    BMC CANCER, 2012, 12
12345